D
Power Law company profile
Dexcom
Health Tech & Medtech · San Diego, United States · Founded 1999 · IPO 2005 Decacorn
Valuation
$22B
Market cap · Apr/2026
Revenue
$4.66B
Latest reported FY
Global footprint
Where Dexcom has talent and traffic
AI talent share
0.8%
of workforce is AI talent
(69 of 8,542 staff)
(69 of 8,542 staff)
Core AI120.14%
Other AI570.67%
Non-AI workforce8,47399.19%
Web traffic by country
2.7M
monthly visits
across markets
across markets
🇺🇸 United States75.9%
🇩🇪 Germany3.5%
🇬🇧 United Kingdom2.9%
🇨🇦 Canada2.9%
🇮🇳 India1.3%
Patent intelligence
$858M patent portfolio · 506 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$858M
4.0% of market cap · 1029× the top peer Neko Health ($834k)
506 active patent families
Where Dexcom innovates
AnalyteSensor systemBiomedical engineeringElectronicsGlucose Measurement
Above peer median on Strategic, Market
Quality vs same-sector peers
Dexcom on the five Patsnap quality dimensions
Dexcom in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Dexcom concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Dexcom and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Dexcom on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.